Robert J. Applegate, MD

Propensity Score Analysis of Vascular Complications after
Diagnostic Cardiac Catheterization and Percutaneous Coronary Interven

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...

Over the past decade clinical...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Differences in Baseline Characteristics and In-hospital Outcomes in Patients with or without Prior Stroke Undergoing Percutaneou

Renato M. Santos , MD;

Cardiac catheterization and PCI are usually performed by percutaneous access using the femoral artery. Following completion of the procedure, hemostasis is traditionally performed by manual compression, followed by 6 hours of bed rest....

Cardiac catheterization and PCI...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Automated Contrast Injection in Contemporary Practice during Cardiac Catheterization and PCI: Effects on Contrast-Induced Nephr

Percutaneous coronary intervention (PCI) is increasingly used in patients with high-risk baseline characteristics.1–4 A prior stroke may identify patients who are at higher risk for post-PCI complications. However, no comparative data exist...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Jason Call , MD;

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

PCI with and without Abciximab after Upstream Eptifibatide Use: Outcomes in High-Risk Patients

Contrast-induced nephropathy (CIN) is a common problem after cardiac catheterization and percutaneous coronary intervention (PCI), and is associated with substantial morbidity and mortality.1–3 The etiology of CIN has not been clearly...

Contrast-induced nephropathy...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Talal T. Baki , MD;

William C. Little , MD;

Culprit Vessel PCI versus Traditional Cath and PCI for STEMI

David C. Sane , MD;

Mark A. Grabarczyk , MD;

Jason E. Goodin , BA;

Sidney Statonk , MD;

Several clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition reduces the ischemic complications of percutaneous coronary interventions (PCI).1–4 Comparative data between agents, however, are very...

Several clinical trials have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Stacy H. Graham , MD;

William C. Little , MD;

Renato M. Santos , MD;

Conversations in Cardiology: Should You Still Prepare the Femoral Site for Radial Cases?

Achieving rapid reperfusion in patients with ST-elevation myocardial infarction (STEM) has been established as an effective and life-saving treatment for these patients. The mortality benefit of primary percutaneous coronary intervention...

Achieving rapid reperfusion in...

08/01/2008

Journal of Invasive Cardiology

04/30/2015

Morton J. Kern , MD, MSCAI, FACC, FAHA;

David J. Cohen , MD, MPH, MSc;

Target Lesion Revascularization after Bare-Metal or Drug-Eluting Stents: Clinical Presentations and Outcomes

Ajay J. Kirtane , MD, SM;

Peter Ver Lee , MD;

David E. Kandzari , MD;

Christopher J. White , DO, MD;

Mauricio G. Cohen , MD, FACC;

Samuel M. Butman , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Aaron V. Kaplan ;

Prashant Kaul , MD, FACC, FSCAI;

Malcolm R. Bell , MD;

Mladen I. Vidovich , MD;

Kirk N. Garratt , MD, MSc;

John Hodgson , MD, FSCAI, FACC;

Michael Krucoff ;

Ramon Quesda ;

Fred Resnick ;

Gus Pichard, Washington Heart Center, asks, “Mort, who among the radialists has stopped shaving the groin?

Gus Pichard, Washington Heart...

04/30/2015

Cath Lab Digest

Original Contribution

06/02/2010

Renato M. Santos , MD;

Kevin R. Hayes , MD;

Hurry, It’s a STEMI! But How Quick is Too Quick for Safety?

William C. Little , MD;

ABSTRACT: Objective. We sought to examine the clinical presentations and subsequent clinical outcomes of patients undergoing target lesion revascularization (TLR) after either bare-metal stent (BMS) or drug-eluting stent (DES) placement....

ABSTRACT: Objective. We...

06/02/2010

Journal of Invasive Cardiology

07/31/2013

David R. Holmes Jr., MD;

E. Magnus Ohman , MD;

Barry F. Uretsky , MD;

Peter B. Berger , MD;

Eric Bates ;

Gregg W. Stone , MD, FACC, FSCAI;

The Angio-Seal Evolution Registry: Outcomes of a Novel Automated Angio-Seal Vascular Closure Device

Sunil V. Rao , MD, FACC, FSCAI;

Ted Feldman , MD, FSCAI, FACC, FESC;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Christopher J. White , DO, MD;

I asked my expert cath lab colleagues to weigh in on this issue with 3 quick answers on whether forced reduction of D2B time is 1) beneficial for the patient or 2) the hospital or 3) the interventionalist, and if you have time, a short...

I asked my expert cath lab...

07/31/2013

Cath Lab Digest

Original Contribution

09/09/2010

David M. Shavelle , MD, FACC, FSCAI;

Zoltan G. Turi , MD;